Serina Therapeutics Files 8-K on Shareholder Nominations
Ticker: SER · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, filing
TL;DR
Serina Therapeutics filed an 8-K on July 1, 2025, covering shareholder nominations and other events.
AI Summary
Serina Therapeutics, Inc. filed an 8-K on July 1, 2025, reporting on shareholder nominations pursuant to Exchange Act Rule 14a-11, Regulation FD disclosure, and other events. The company, formerly known as AgeX Therapeutics, Inc. until June 6, 2017, is located in Huntsville, Alabama.
Why It Matters
This filing indicates potential changes or discussions related to the company's board of directors or governance structure, which could impact strategic direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose immediate financial or operational risks.
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Registrant
- July 1, 2025 (date) — Date of Report
- AgeX Therapeutics, Inc. (company) — Former Company Name
- June 6, 2017 (date) — Date of Name Change
- Huntsville, Alabama (location) — Principal Executive Offices
FAQ
What specific items are being reported under 'Other Events'?
The filing mentions 'Other Events' as an item information but does not specify the details within the provided text.
What is the significance of 'Shareholder Nominations Pursuant to Exchange Act Rule 14a-11'?
This item indicates that the company is reporting on nominations made by shareholders, potentially for board positions, under a specific SEC rule.
What is the company's primary business as indicated by its SIC code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to 'Pharmaceutical Preparations'.
When did the company change its name from AgeX Therapeutics, Inc.?
The company changed its name from AgeX Therapeutics, Inc. on June 6, 2017.
What is the filing date and the period of report for this 8-K?
The filing date and the conformed period of report are both July 1, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Serina Therapeutics, Inc. (SER).